USA stockpiling of remdesivir: How should the world respond?

The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawoud, Dalia, Chalkidou, Kalipso, Sullivan, Richard, Ruiz, Francis J, Adler, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717394/
https://www.ncbi.nlm.nih.gov/pubmed/33274643
http://dx.doi.org/10.2217/cer-2020-0174
_version_ 1783619308660719616
author Dawoud, Dalia
Chalkidou, Kalipso
Sullivan, Richard
Ruiz, Francis J
Adler, Amanda
author_facet Dawoud, Dalia
Chalkidou, Kalipso
Sullivan, Richard
Ruiz, Francis J
Adler, Amanda
author_sort Dawoud, Dalia
collection PubMed
description The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence.
format Online
Article
Text
id pubmed-7717394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-77173942020-12-04 USA stockpiling of remdesivir: How should the world respond? Dawoud, Dalia Chalkidou, Kalipso Sullivan, Richard Ruiz, Francis J Adler, Amanda J Comp Eff Res Commentary The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence. Future Medicine Ltd 2020-12-04 2020-10 /pmc/articles/PMC7717394/ /pubmed/33274643 http://dx.doi.org/10.2217/cer-2020-0174 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Commentary
Dawoud, Dalia
Chalkidou, Kalipso
Sullivan, Richard
Ruiz, Francis J
Adler, Amanda
USA stockpiling of remdesivir: How should the world respond?
title USA stockpiling of remdesivir: How should the world respond?
title_full USA stockpiling of remdesivir: How should the world respond?
title_fullStr USA stockpiling of remdesivir: How should the world respond?
title_full_unstemmed USA stockpiling of remdesivir: How should the world respond?
title_short USA stockpiling of remdesivir: How should the world respond?
title_sort usa stockpiling of remdesivir: how should the world respond?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717394/
https://www.ncbi.nlm.nih.gov/pubmed/33274643
http://dx.doi.org/10.2217/cer-2020-0174
work_keys_str_mv AT dawouddalia usastockpilingofremdesivirhowshouldtheworldrespond
AT chalkidoukalipso usastockpilingofremdesivirhowshouldtheworldrespond
AT sullivanrichard usastockpilingofremdesivirhowshouldtheworldrespond
AT ruizfrancisj usastockpilingofremdesivirhowshouldtheworldrespond
AT adleramanda usastockpilingofremdesivirhowshouldtheworldrespond

Ejemplares similares